Clinical note: This table is illustrative only
You may not be eligible if you: Have a BMI over 35 Have uncontrolled heart, metabolic, or cognitive conditions Use insulin, or medications that significantly affect weight Are planning major lifestyle changes (e.g., starting keto or intensive workouts) Have a history of eating disorders, bariatric surgery, or pancreatitis Are taking certain hormones, steroids, or investigational medications Are pregnant, nursing, or planning pregnancy (or capable of pregnancy without contraception) Well go over the full list with you during the screening
The article says semaglutide was approved for chronic weight management on June 4, 2021, under the brand name Wegovy
This pace minimizes muscle loss, maintains metabolic rate, and allows time for behavioral adaptation and habit formation
These improvements can decrease the risk of developing serious conditions such as heart disease, type 2 diabetes, and certain types of cancer